|
Administration Core |
1P01AG073090-01A1 |
|
NIA |
2022 |
|
Parenchymal border macrophages in AD and CAA |
1P01AG078106-01 |
|
NIA |
2022 |
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
1P01AG078106-01 |
|
NIA |
2022 |
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
1P01AG078106-01 |
|
NIA |
2022 |
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
1P01AG078116-01 |
|
NIA |
2022 |
|
Project 2 - Astrocytic insulin signaling and AD |
1P01AG078116-01 |
|
NIA |
2022 |
|
NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course) |
1R25AG076392-01 |
|
NIA |
2022 |
|
The Hopkins Undergraduate Summer Training and Research (USTAR) Program |
1R25AG076635-01 |
|
NIA |
2022 |
|
Alzheimers-focused Celdara Medical High-Potential Entrepreneurial Fellowship Program (A-CHEF) |
1R25AG078135-01 |
|
NIA |
2022 |
|
An Immersive, Interdisciplinary Training Program for Workforce Development and Sustained Engagement in Entrepreneurship and Translational Research for Alzheimers Disease and Related Disorders |
1R25AG078147-01 |
|
NIA |
2022 |